Chen, Dongxuan
Lau, Yiu-Chung https://orcid.org/0000-0001-6618-9094
Xu, Xiao-Ke
Wang, Lin https://orcid.org/0000-0002-5371-2138
Du, Zhanwei https://orcid.org/0000-0002-2020-767X
Tsang, Tim K. https://orcid.org/0000-0001-5037-6776
Wu, Peng https://orcid.org/0000-0003-1157-9401
Lau, Eric H. Y. https://orcid.org/0000-0002-6688-9637
Wallinga, Jacco
Cowling, Benjamin J. https://orcid.org/0000-0002-6297-7154
Ali, Sheikh Taslim https://orcid.org/0000-0002-8631-9076
Funding for this research was provided by:
Food and Health Bureau of the Government of the Hong Kong Special Administrative Region | Health and Medical Research Fund (20190712)
Research Grants Council, University Grants Committee (C7123-20G)
Innovation and Technology Commission (AIR@InnoHK)
Article History
Received: 8 August 2022
Accepted: 7 December 2022
First Online: 13 December 2022
Change Date: 10 January 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-023-35855-z
Competing interests
: B.J.C. consults for AstraZeneca, Fosun Pharma, GSK, Haleon, Moderna, Pfizer, Roche, and Sanofi Pasteur. The remaining authors declare no competing interests.